We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$91.2B
AUM Growth
+$11.2B
Cap. Flow
+$2B
Cap. Flow %
2.19%
Top 10 Hldgs %
23.22%
Holding
3,971
New
387
Increased
1,763
Reduced
1,480
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 14.58%
2 Healthcare 8.49%
3 Financials 8.3%
4 Consumer Discretionary 6.61%
5 Industrials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBM
3901
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
-33,599
Closed -$528K
HDS
3902
DELISTED
HD Supply Holdings, Inc.
HDS
-149,182
Closed -$6.15M
GLIBA
3903
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
-661,486
Closed -$54.2M
IBDL
3904
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
-396,915
Closed -$10M
DNKN
3905
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-45,211
Closed -$3.7M
BFO
3906
DELISTED
Blackrock Florida Municipal 2020 Term Trust
BFO
-26,894
Closed -$396K
BSJK
3907
DELISTED
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
-76,323
Closed -$1.78M
NTRP
3908
DELISTED
Neurotrope, Inc. Common
NTRP
-11,773
Closed -$13K
NBRV
3909
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-149
Closed -$20K
TLI
3910
DELISTED
Western Asset Corporate Loan Fund Inc.
TLI
-33,093
Closed -$306K
MYOK
3911
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-13,984
Closed -$1.91M
WMGI
3912
DELISTED
Wright Medical Group Inc
WMGI
-121,925
Closed -$3.72M
JCAP
3913
DELISTED
Jernigan Capital, Inc.
JCAP
-39,990
Closed -$685K
LVGO
3914
DELISTED
Livongo Health, Inc. Common Stock
LVGO
-23,153
Closed -$3.24M
JHY
3915
DELISTED
Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest
JHY
-113,396
Closed -$1.07M
IMMU
3916
DELISTED
Immunomedics Inc
IMMU
-3,455
Closed -$294K
LONE
3917
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
-21,732
Closed -$5K
DNI
3918
DELISTED
Dividend and Income Fund
DNI
-402,924
Closed -$3.67M
AMTD
3919
DELISTED
TD Ameritrade Holding Corp
AMTD
-167,218
Closed -$6.55M
ETFC
3920
DELISTED
E*Trade Financial Corporation
ETFC
-12,038
Closed -$603K
WPG
3921
DELISTED
Washington Prime Group Inc.
WPG
-2,003
Closed -$12K
MFT
3922
DELISTED
BLACKROCK MUNIYIELD INVESTMENT QUALITY FUND
MFT
-11,156
Closed -$153K
BSCK
3923
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
-543,244
Closed -$11.5M
LUNA
3924
DELISTED
Luna Innovations Incorporated
LUNA
-41,367
Closed -$247K
PEI
3925
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
-864
Closed -$7K

Similar funds

Raymond James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Raymond James & Associates held 3,971 positions worth $91.2B, up 14% from $80B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2020 filing shows 387 new, 1,763 increased, 1,480 reduced and 217 closed positions. Its largest new stake was Bentley Systems: 330,402 shares worth $13.4M. The largest sale was United Parcel Service, an estimated $69.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2020 buy was Bentley Systems: 330,402 shares worth $13.4M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $158M increase.
  • Raymond James & Associates's biggest Q4 2020 reduction was United Parcel Service, cutting an estimated $69.6M.
  • Raymond James & Associates fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q4 2020, selling an estimated $54.2M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $91.2B portfolio in Q4 2020.
  • Raymond James & Associates opened 387 new positions and closed 217 in Q4 2020.
  • Raymond James & Associates's portfolio value rose 14% quarter-over-quarter to $91.2B.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.